|
Search
Collections
Benchmarks
Upload document
Organization
Nathan Denlinger
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
Clinical trial
Early, Risk Adapted CC-99282 + Rituximab Post CAR T-Cell Therapy for Non-Hodgkin's Lymphoma
Status: Recruiting
, Estimated PCD: 2025-12-31
